Skip to main content
Log in

Cardiac resynchronization therapy and outcomes in patients with left ventricular assist devices: a systematic review and meta-analysis

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

The impact of cardiac resynchronization therapy (CRT) on clinical outcome in patients with a continuous-flow left ventricular assist device (LVAD) is currently not well understood. We conducted a systematic literature review and meta-analysis with an intention to summarize all published clinical evidence. We searched MEDLINE and EMBASE databases through March 2018 for studies that compared the outcomes in patients with LVAD and CRT. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated using a random-effects model, inverse variance method. The between-study heterogeneity was assessed using the Q statistic and I2. A total of seven studies that included 1157 (575 CRT; 582 non-CRT) patients were identified. Our meta-analysis did not demonstrate a significant difference in the risk of mortality (pooled OR = 1.21, 95% CI 0.90–1.63, P = 0.21), ventricular arrhythmia incidence (pooled OR = 1.36, 95% CI 0.99–1.86, P = 0.06), hospitalization (pooled OR = 1.36, 95% CI 0.59–3.14, P = 0.48), or implantable cardioverter defibrillator therapies (pooled OR = 1.08, 95% CI 0.51–2.30, P = 0.84) among the CRT group compared with the non-CRT group. There was high heterogeneity with an I2 of 75% for ICD therapies. Among LVAD patients, CRT combined did not significantly affect mortality, re-hospitalization, ventricular arrhythmia incidence, and ICD therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Savarese G, Lund LH (2017) Global public health burden of heart failure. Card Fail Rev 3(1):7–11

    Article  PubMed  Google Scholar 

  2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Mabo P, Lazarus A, Ritter P, Levy T, McKenna W, Daubert JC (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344(12):873–880

    Article  PubMed  CAS  Google Scholar 

  3. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J, MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346(24):1845–1853

    Article  PubMed  Google Scholar 

  4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, de Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries D, Feldman AM, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150

    Article  PubMed  CAS  Google Scholar 

  5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549

    Article  PubMed  CAS  Google Scholar 

  6. MacIver J, Ross HJ (2012) Quality of life and left ventricular assist device support. Circulation 126(7):866–874

    Article  PubMed  Google Scholar 

  7. Gopinathannair R, Roukoz H, Bhan A et al (2017) Cardiac resynchronization therapy versus ICD on clinical outcomes in continuous flow LVAD recipients: a multicenter analysis. Heart Rhythm 14(5):S84

    Google Scholar 

  8. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605

    Article  PubMed  Google Scholar 

  9. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  Google Scholar 

  10. Richardson TD, Hale L, Arteaga C, Xu M, Keebler M, Schlendorf K, Danter M, Shah A, Lindenfeld JA, Ellis CR (2018) Prospective randomized evaluation of implantable cardioverter- defibrillator programming in patients with a left ventricular assist device. J Am Heart Assoc 7(5)

  11. Kutyifa V, Fernandez G, Sherazi S et al (2016) Lack of association between cardiac resynchronization therapy and improved survival in left ventricular assist device patients. Heart Rhythm 13(5):S531

    Google Scholar 

  12. Mai TV, Minnier J, Mudd JO et al (2016) Arrhythmic effects of cardiac resynchronization therapy versus implantable cardiac defibrillator in patients with a left ventricular assist device. Heart Rhythm 13(5):S185

    Google Scholar 

  13. Choi AD, Fischer A, Anyanwu A, Pinney S, Adler E (2010) Biventricular pacing in patients with left ventricular assist devices - is left ventricular pacing proarrhythmic. J Am Coll Cardiol 55(10):A22.E208

    Article  Google Scholar 

  14. Rao P (2015) Cardiac resynchronization therapy in left ventricular assist device patients. Heart Rhythm 12(5):S218

    Google Scholar 

  15. Hottigoudar RU, Birks EJ, Trivedi J et al (2013) Cardiac resynchronization therapy does not offer additive benefit over ICD in patients with continuous flow left ventricular assist device. Heart Rhythm 10(5):S112

    Google Scholar 

  16. Koplan BA, Kaplan AJ, Weiner S, Jones PW, Seth M, Christman SA (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 53(4):355–360

    Article  PubMed  Google Scholar 

  17. Hayes DL, Boehmer JP, Day JD, Gilliam FR III, Heidenreich PA, Seth M, Jones PW, Saxon LA (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8(9):1469–1475

    Article  PubMed  Google Scholar 

  18. Ruwald AC, Kutyifa V, Ruwald MH, Solomon S, Daubert JP, Jons C, Brenyo A, McNitt S, Do D, Tanabe K, al-Ahmad A, Wang P, Moss AJ, Zareba W (2015) The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. Eur Heart J 36(7):440–448

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dinesh Chandra Voruganti.

Electronic supplementary material

ESM 1

(PDF 37 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Voruganti, D.C., Briasoulis, A., Chaudhry, M. et al. Cardiac resynchronization therapy and outcomes in patients with left ventricular assist devices: a systematic review and meta-analysis. Heart Fail Rev 24, 229–236 (2019). https://doi.org/10.1007/s10741-018-9740-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-018-9740-x

Keywords

Navigation